Pouya Dayani is an Ophthalmology physician affiliated with University of Southern California. OpenAlex indexes 32 publications with 1,504 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1245 Wilshire Blvd
380
Los Angeles, CA 900174810
Telephone
213-483-8810Provider last certified this registry record 25 Jun 2021.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202511 payments
- Apellis Pharmaceuticals, Inc.Program year20257 payments
- ABBVIE INC.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
95.1%Antineovascularisation agents91.8%Faricimab-svoa100%Part B, office-administered≥107 patientsCorticosteroid0.6%Prednisolone Acetate100%Part D≥107 patients+ 6 more classes in this area
Cancer & immunology
3.8%Complement Inhibitor2.1%Pegcetacoplan100%Part B, office-administered≥11 patientsVascular Endothelial Growth Factor Inhibitor1.6%Aflibercept100%Part B, office-administered≥74 patients+ 1 more class in this area
Musculoskeletal
0.4%Cyclooxygenase Inhibitor0.4%Ketorolac Tromethamine100%Part D≥84 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
Journal of VitreoRetinal Diseases
2024 - Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)
British Journal of Ophthalmology
2021 - Crystalline Maculopathy Secondary to Retinal Tear Without Detachment
Journal of VitreoRetinal Diseases
2021
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”